The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability

Erinc Hallacli(Max Perutz Labs), Vikram Khurana(Broad Institute), Xiou H. Wang(Harvard University), D.R. Mani(Broad Institute), J. Timothy Greenamyre(University of Pittsburgh), Chad L. Myers(Twin Cities Orthopedics), Namrata D. Udeshi(Harvard University), Zoe Sheinkopf(Brigham and Women's Hospital), Steven A. Carr(Broad Institute), Aazam Vahdatshoar(Harvard University), Chee Yeun Chung(Whitehead Institute for Biomedical Research), Sumaiya Nazeen(Brigham and Women's Hospital), Shubhangi Sathyakumar(Brigham and Women's Hospital), Matthew T. Keeney(Brigham and Women's Hospital), Xin Jiang(Tsinghua University), Roberto Di Maio(University of Pittsburgh), Philip L. De Jager(Broad Institute), Jackson Sandoe(Whitehead Institute for Biomedical Research), Xianjun Dong(Yale University), Shamil Sunyaev(Harvard University), Daniel Felsky(Centre for Addiction and Mental Health), Can Kayatekin(Whitehead Institute for Biomedical Research), David P. Bartel(Howard Hughes Medical Institute), Wen Wang(Hunan University of Traditional Chinese Medicine), Souvarish Sarkar(University of Rochester Medical Center), Susan Lindquist(Howard Hughes Medical Institute), Mel Β. Feany(Brigham and Women's Hospital)
Cited by 167


Related Papers